Background: The ideal spread of local anesthetic for effective, rapid,
S ciatic nerve block in the popliteal fossa is a commonly used peripheral nerve block for surgery below the knee. The overall success rate of the block at 30 minutes, using ultrasound guidance, ranges from 60% to 100%. [1] [2] [3] The question of the ideal location and spread of local anesthetic (LA) resulting in effective, rapid, and safe sciatic nerve block remains. 4 The sciatic nerve divides into tibial and common peroneal components at the popliteal fossa and is surrounded by a closely adherent connective tissue layer, the paraneural sheath. [5] [6] [7] Depending on where the needle tip is inserted and the spread of LA solution, significant differences in onset time and duration of sensory and motor blockades have been reported. [8] [9] [10] [11] [12] [13] The recent literature highlights the importance of obtaining an extraneural concentric distribution of LA around the sciatic nerve 1, 14, 15 or an extraneural injection surrounding both tibial and peroneal nerves distal to the bifurcation. 12, 13, 16 In 2 studies, a proximal injection below the paraneural sheath seemed superior to an extraneural distal injection around both separate tibial and peroneal nerves. 8, 10 Only 1 study focused on LA volume, 11 compared extraneural circumferential spread with subparaneural (subfascial) spread of LA solution around the sciatic nerve bifurcation. On one hand, the pharmacodynamic importance of the common paraneural sheath is questionable. 17, 18 On the other hand, although unintentional intraepineural injection has now been reported in 6% to 17% of ultrasound-guided peripheral nerve blocks, 8, 19, 20 no study has reported the block pharmacodynamic profile related to unintentional intraepineural injections. In this randomized double-blind study, we hypothesized that a subparaneural ultrasound-guided injection of LA results in faster onset and has a better success rate than extraneural circumferential spread of LA around the entire sciatic nerve at the bifurcation level. We also evaluated the block pharmacodynamic profile of the unintentional intraepineural injections.
METHODS
After institutional ethical committee approval (CPP Sud Mediterranée III, Nimes, France), registration in the French Database for Clinical Trials (EUDRACT no. 2010-A00289-30), and written informed consent, patients scheduled for elective tibial, foot, and ankle surgery with popliteal sciatic nerve blocks were prospectively enrolled in this study. The design and description of the study adhered to the guidelines of the Consolidated Standards of Reporting Clinical Trials (CONSORT) statement. Exclusion criteria were the presence of a bleeding disorder, peripheral neuropathy or chronic pain syndrome, infection or injury at the needle entry point, allergy to LA, patients less than 18 years of age, pregnancy, cognitive impairment, patient refusal, and participation in another clinical trial. Patients were randomly assigned to receive circumferential extraneural or subparaneural ultrasound-guided injections of LA at the level of the popliteal sciatic nerve bifurcation. Randomization was generated by our institutional biostatistics department using a computer-generated random sequence. The anesthesiologist in charge of the patient performed the ultrasound-guided block according to the randomization group. The patient, surgeon, and anesthesiologist collecting the data were blinded to the type of block performed.
On the day of surgery, patients were given oral premedication (hydroxyzine 1 mg/kg) 90 minutes before the procedure and 500 mL of saline were infused with an intravenous 20-gauge catheter. Patients underwent systematic administration of oxygen at a rate of 6 L/min. Standard monitoring was used, including noninvasive arterial blood pressure, heart rate, and pulse oximetry. Each patient was placed in the prone position, with a pillow under the anterior part of the ankle to permit free movement of the foot during nerve stimulation. During the procedure, all patients received sedation via target-controlled infusion (propofol, Marsh model, concentration at the site of action 1.2 ng/mL). Ultrasound-guided lateral, short-axis, in-plane sciatic popliteal nerve blocks (linear array probe LA 435K, 8-18 MHz; Agile, Kontron Medical, France) were performed by anesthetists with more than 3 years' experience with ultrasoundguided blocks. The skin was prepared with an alcoholic povidoneiodine solution. An insulated, 22-gauge, 50-mm needle (Stimuplex A; BBraun, Germany) was advanced at an angle of 90 degrees to the skin until the tip was positioned according to the randomization group. The needle tip position was adjusted as necessary within the selected target to ensure circumferential extraneural or subparaneural spread of LA around the sciatic nerve (Fig. 1A,  B) . A nerve stimulator (Stimuplex HNS 12; BBraun) was set to a pulse duration of 0.1 millisecond, current intensity of 0.2 mA, and frequency of 1 Hz. Once the needle was in place, the physician verified that there was no motor response to nerve stimulation, no paresthesia, and no blood aspiration occurred. Mepivacaine 10 mg/mL was injected in 5-mL increments to a total volume of 0.3 mL/kg, with a maximum of 30 mL. A video of the ultrasound-guided block sequence was recorded and stored for post hoc analysis. A second anesthesiologist blinded to the patient randomization group collected the data: duration of the procedure, needle passes, onset time of sensory and motor blockades in sciatic nerve components, duration of the block, and paresthesia or pain during the procedure. The blinded anesthesiologist did not have the opportunity to see the screen of the ultrasound machine during the procedure and to know the patient group allocation. Sensory blockade was assessed every 3 minutes after injection as a loss of cold, pinprick, and light touch sensations in the areas of the tibial (plantar surface of the foot) and common peroneal (dorsal surface of the foot) nerves. Sensory blockade was classified as follows: 0, anesthesia; 1, hypoesthesia; 2, normal sensation. At the same time, motor blockade was tested for the tibial nerve (plantar flexion of the foot) and the common peroneal nerve (dorsal flexion of the foot). Motor blockade was classified as follows: 0, complete motor blockade; 1, weak response against resistance; 2, no motor blockade. A block was considered successful (block permitting surgery) when a score of 0 was obtained for sensory blockade, whatever the score for motor blockade in the sciatic nerve components is. A block was considered a failure if a score of 0 was not obtained for sensory blockade within 30 minutes after LA injection in the areas tested. The duration of sensory and motor block was evaluated by the anesthesiologist blinded to the type of block (light touch and foot movements) within the first 6 hours in the postanesthetic care unit.
After every 10 patients, an expert anesthesiologist not involved in the study randomly reviewed ultrasound video clips of the injections and scored the ultrasound criterion. Crosssectional short-axis sciatic nerve measurements were recorded for the common sciatic nerve and both nerve components. Changes in nerve dimension and appearance (swelling) were measured and noted. Using post hoc video analysis, including measurements of the diameter of sciatic nerve components before and after LA injection, the patients were separated into 3 groups depending on the characteristics of LA spread: extraneural, subparaneural, or unintentional intraepineural spread. Extraneural and subparaneural spread of LA solution was defined as previously reported. 8, 10, 11, 14 Unintentional intraepineural injection associated with extraneural or subparaneural spread of LAwas defined as an increase in the diameter of one or both sciatic nerve components of more than 10%, with swelling and fascicular separation ( Fig. 2A, B) . [21] [22] [23] Patients were contacted by phone 24 hours and 1 week postoperatively to document any remaining motor or sensory deficits. Patients were followed up by the surgeon on the day of surgery to assess full recovery from the nerve block and again 1 week later. Complete recovery from the block and the lack of residual postoperative neurologic symptoms such as paresthesia, dysesthesia, or motor deficits were carefully noted by the patients and the surgical team in a specific file.
Sample Size Calculation and Statistical Analysis
The primary end point in both patient groups was the onset time of sensory blockade. The mean onset time of sensory block for ultrasound-guided circumferential extraneural injection just before sciatic nerve bifurcation is between 26 and 31 minutes. 12, 13 We hypothesized a 30% reduction in the onset time with subparaneural injection at the site of bifurcation. We assumed a standard deviation of 10 minutes. For a 2-tailed α = 0.05 and a power of 80%, a sample size of 24 patients per group was required. To allow for a dropout of 10% of patients, 60 patients were randomized. Statistics are presented as median (minimum-maximum) for quantitative data and numbers (percentage) for qualitative parameters. Continuous variables were compared using the MannWhitney U test or the Kruskal-Wallis test. Discrete variables were compared using the χ 2 test or the Fisher exact test when indicated. For multiple comparisons, a Bonferroni correction was applied. Avalue of P < 0.05 was considered statistically significant. Statistical analyses were performed using SAS software (version 8.2; SAS Institute Inc, Cary, North Carolina).
RESULTS
Sixty consecutive patients consented to participate in the study and were randomly assigned to one of the 2 groups (Fig. 3) . Forty-eight patients completed the study assessments and were included in the final analysis: 26 (43.3%) in the subparaneural group and 22 (36.7%) in the extraneural group. Twelve patients (20%) were excluded after randomization because of protocol violations, incomplete data, or a sciatic nerve that was poorly visualized. In the extraneural group, 6 patients (10%) presented block failure (incomplete sensory blockade after 30 minutes). The demographic data for the 48 patients studied are presented in Table 1 . There was no significant difference between patients for anthropometric characteristics, procedure time, volume of LA, number of needle passes, and type of surgery. No motor response to nerve stimulation was observed. The onset time for surgical block in the subparaneural group was shorter than in the extraneural group (respectively, median [range] values at 11 [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] minutes and 17 minutes, for surgical block excluding the 6 failure patients), and sensory blockade of the tibial nerve lasted longer. With regard to the failure rate, the 6 patients presenting block failure (incomplete sensory blockade after 30 minutes) belonged to the extraneural group. After post hoc echographic analysis, 21 (43.8%) of 48 extraneural injections, 23 (47.9%) of 48 subparaneural spreads, and 4 (8.3%) of 48 unintentional intraepineural injections were observed ( Table 2 ). The patients in the unintentional intraepineural spread group had shorter onset time for surgical block than those in the subparaneural and extraneural groups. The duration of sensory blockade was significantly shorter in the extraneural group compared with the subparaneural and unintentional intraepineural groups. The onset time of sensory and motor blockade according to the location of the LA spread are presented in Figure 4 . No patients reported neurologic complications or paresthesia.
DISCUSSION
In this prospective randomized study, we found that, compared with a circumferential extraneural injection at the bifurcation level of the sciatic nerve, a subparaneural injection at the same level resulted in earlier onset of surgical block, a better success rate, and increased duration of tibial nerve sensory blockade. However, the onset time was significantly shorter in patients with unintentional intraepineural spread compared with subparaneural or extraneural injections.
Our study compared circumferential extraneural and subparaneural injections performed strictly at the same level. Both parameters have been considered as factors to improve the success rate and decrease block onset time in patients. [8] [9] [10] [11] 14, 15 Previous studies evaluated the benefit of injections targeting both the distal tibial and common peroneal nerves compared with proximal extraneural injections, 12,13,16 subparaneural proximal to distal extraneural injections, 9,10 or at 2 different levels of the paraneural compartment. 8 We noted quite the same results concerning the onset time in subparaneural and extraneural groups than in the study by Perlas et al. 10 However, the injections of LA solution were differently located along the sciatic nerve course. Perlas et al 10 compared a proximal subparaneural injection with a double more distal (probably 4-5 cm distally from the injection point of the subparaneural group) extraneural injection on the 2 separated nerve components. This is a difference between our 2 studies despite the overlap in the spread of LA solution between both Perlas et al 10 study groups. In anatomic 5 and 3-dimensional ultrasound 11 studies focused on LA spread, it has been demonstrated that the mean paraneural distance covered by LA spread can reach 9 cm, erasing the expected difference between injections at the prebifurcation and bifurcation levels. Our results highlight the fact that paraneural injection is more important than circumferential spread in the pharmacodynamic profile of a popliteal sciatic nerve block. 17, 18 In an in vitro study on rat sciatic nerves, Leeson and Strichartz 18 reported that the paraneural sheath halved the uptake rate of lidocaine, penetration into the nerve, and the washout rate. This experimental report confirms our results, which demonstrate a significant decrease in surgical block onset time and a prolonged duration of sensory blockade in patients receiving a subparaneural injection. Missair et al 11 reported identical results with a shorter onset time and a longer duration of sciatic nerve blocks in patients receiving 30 mL of 0.5% ropivacaine subfascially compared with patients receiving the same volume extrafascially. However, the authors did not separate the duration of sensory blockade in the common peroneal and tibial nerves. We report that the difference in block duration is effective for the tibial nerve but not for the common peroneal nerve.
An injection inside the common sheath can be differentiated from an intraneural injection. In 4 patients (8.5%) in our post hoc analysis, an intraepineural injection was noted. Three of the patients noted with an intraepineural location of LA belonged to the subparaneural group and one to the group extraneural (NS). Published data suggest that a subparaneural spread of LA may be recommended. 7, 9, 10, 24 However, there is a need for comparative studies to establish a safe and objective method of performing such an injection. Despite the absence of nerve injuries in our 4 patients of the intraepineural group, it has been reported that patients who received a subparaneural injection noted a higher incidence of transient paresthesia.
12 As Karmakar and colleagues 24 recently reported, using low-resolution ultrasound systems do not ensure that the tip of the needle is strictly outside the epineural space. Furthermore, the lack of sensitivity of nerve stimulation does not allow to detect the needle's tip position within the epineurium ( absence of motor response at 0.2 mA).Unintentional intraneural injections have been reported in 6% 8 to 17% 19, 20 of ultrasound-guided peripheral nerve blocks. As previously demonstrated in subgluteal sciatic nerve blocks, 19 we report that an intraepineural injection associated with a subparaneural or an extraneural spread significantly shortened the onset time of sciatic nerve block compared with a nonintraepineural spread in the other 2 groups. Hara et al 19 did not report any difference in the duration of the block between the intraneural and nonintraneural injection groups. However, the authors did not distinguish between extraneural extrafascial and paraneural (subfascial) injections. We report a significant difference in the duration of tibial sensory block between the unintentional intraepineural injection group and the extraneural injection group but not the subparaneural group, highlighting the importance of the paraneural sheath in the pharmacodynamic profile of the block. That difference can be related to the structural aspects of both nerves, 25 the relationship the components have with the paraneural sheath as a barrier to LA spread, and the vascularization of the common peroneal nerve that limits the washout of the LA, and so increases the duration of the block. 26 There are some limitations in the present study. Like most procedure-related studies, it is not possible to blind the anesthesiologist doing the block to group allocation. To minimize the possibility of bias, the procedure was assessed and the block pharmacodynamic parameters were documented by an independent physician blinded to the group allocation. We reported no neurologic deficit even in the unintentional intraepineural group. The study was not powered to detect clinically meaningful differences with regard to safety.
In conclusion, the results of this study suggest that a subparaneural injection at the sciatic nerve bifurcation level results in faster onset and longer duration of sensory blockade than a circumferential extraneural injection. This highlights the importance of the paraneural sheath in the pharmacodynamic profile of the block. Furthermore, associated unintentional intraepineural injection decreased the onset time of sensory and motor blockade further.
